본문
Jae Min Jeong, Ph.D.
Radiopharmaceutical
| Education | ||
| • | Mar. 77 - Feb. 82 | B.Sc. College of Pharmacy, Seoul National University |
| • | Mar. 82 - Feb. 84 | M.Sc. Biochemistry, College of Pharmacy, Seoul National University |
| • | Mar. 84 - Feb. 89 | Ph.D. Biochemistry, College of Pharmacy, Seoul National University |
| Appointment | ||
| • | Mar. 1983 – Dec. 1983 | Teaching Assistant, Department of Biochemistry, College of Pharmacy, Seoul National University |
| • | May. 1985 – Dec. 1989 | Research Scientist, Central Laboratory, Seoul National University Hospital |
| • | Mar. 1986 – Jul. 1986 | Instructor, Department of Biochemistry, College of Natural Science, Kangwon National University |
| • | Dec. 1989 – Aug. 1990 | Consultant, Department of Nuclear Medicine, Seoul National University Hospital |
| • | Sep. 1990 – Sep. 1993 | Visiting fellow, Department of Nuclear Medicine, National Institutes of Health, U.S.A. |
| • | Sep. 1993 – Feb. 1994 | Researcher, Department of Nuclear Medicine, Seoul National University Hospital |
| • | Mar. 1994 – Present | Director, Cyclotron and Radiochemistry, Department of Nuclear Medicine, Seoul National University Hospital |
| • | Mar. 1994 – Feb. 1996 | Instructor, Seoul National University College of Medicine |
| • | Mar. 1996 – Feb. 1999 | Assistant Professor, Seoul National University College of Medicne |
| • | Mar. 1999 – Mar. 2005 | Associate Professor, Seoul National University College of Medicne |
| • | Jun. 28th 2001 – Present | Supervisor of Pharmaceutical Manufacturing, Seoul National University Hospital |
| • | Apr. 2005 – Present | Professor, Seoul National University College of Medicine |
| • | Jan 1st 2003 – Oct 27th 2006 | Deputy Chairperson, International Policy Research Committee, World Federation of Nuclear Medicine and Biology |
| • | Jan. 2002 – Dec. 2008 | Executive Manager, Radiopharmaceutical Committee, Korean Society of Nuclear Medicine |
| • | Jan. 10th 2005 – 2012 | Director, Radiation Safety Office, Seoul National University Hospital |
| • | Jan. 2002 – Dec. 2008 | Manager of Nuclear Scientists, Korean Society of Nuclear Medicine |
| • | Jan. 1999 – Dec. 2001 | Editorial Board, Korean Journal of Nuclear Medicine |
| • | Feb. 2006 – present | Appointment for Radiation Safety, Seoul National University College of Medicine |
| • | Oct. 1st 2006 – present | Research safety management committee (IBC) of Clinical Research Institute, Seoul National University Hospitl |
| • | Jun. 1st 2008 – 2016 | Director, Brain Plasticity Imaging National Research Laboratory |
| • | Apr. 14th 2008 | Steering Committee Member of Korean PET Association |
| • | Apr. 2008 – present | Radiopharmaceutical Committee Member of Korean Radioisotope Association |
| • | Jan. 2009 – Dec. 2010 | Manager of Publish, Korean Society of Nuclear Medicine |
| • | Jan. 2009 – present | Associate Editor, Nuclear Medicine and Molecular Imaging |
| • | Jan. 2009 – present | Editorial Board, Nuclear Medicine and Biology |
| • | Apr. 8th 2009 – present | Radiation Safety Committee Member of Korean Radioisotope Association |
| • | Sep. 2010 – Aug. 2014 | Institution Review Board Member of Seoul National University Hospital |
| • | Sep. 1st 2011 – present | Board of Directors, Society of Radiopharmaceutical Sciences |
| • | Sep. 1st 2011—Oct. 2013 | Secretary General, 29th International Symposium on Radiopharmaceutical Sciences |
| • | Aug. 2012 – present | Editorial Board, American Journal of Nuclear Medicine and Molecular Imaging |
| • | Jun. 26th 2013 – present | Editorial Board, The Journal of Nuclear Medicine |
| • | Feb. 2014 – Apr. 2016 | President, Korean Society of Radiopharmaceuticals and Molecular Probes |
| • | Jan. 2015 – present | Editor-in-chief, J Radiopharm Mol Probs |
| • | May. 31 2015 – present | President-Elect, Society of Radiopharmaceutical Sciences |
Research Activity |
||
| • | Development of radiopharmaceuticals for diagnosis or therapy. | |
| • | Development of 188Re-lipiodol for treatment of liver cancer | |
| • | Development of 188Re-tin colloid for treatment of rheumatoid arthritis | |
| • | Development of 99mTc-labeled neolactosylated human serum albumin for asialoglycoprotein receptor imaging | |
| • | Development of 99mTc-labeled neomannosylated human serum albumin for sentinel node imaging | |
| • | Development of 18F-fluoroflumazenil for benzodiazepine receptor imaging | |
| • | Development of 68Ga-labeled RGD derivatives as angiogenesis imaging agent | |
| • | Forgarty Fellowship Award (Sep. 1990 – Sep. 1993) | |
| • | Distinguished Service Award by Korea Radioisotope Association (Sep. 2005) | |
| • | Nuclear Medicine Academy Award by Korean Society of Nuclear Medicine (Oct. 27th 2012) | |
| Membership in Professional Organization | ||
| • | Korean Society of Biochemistry | |
| • | Korean Society of Pharmacy | |
| • | Korean Society of Nuclear Medicine | |
| • | Korean Society of Chemistry | |
| • | Society of Nuclear Medicine (U.S.A.) | |
| • | Society of Radiopharmacology | |
| • | American Chemical Society | |
| • | Society of Radiopharmaceutical Sciences | |
